Boston, MA -- (SBWIRE) -- 09/02/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Affymax, Inc.(OTCMKTS:AFFY), ValueClick Inc(NASDAQ:VCLK), United Online, Inc.(NASDAQ:UNTD), Keryx Biopharmaceuticals(NASDAQ:KERX)
Affymax, Inc.(OTCMKTS:AFFY) decreased -8.77% and closed at $1.56 on a traded volume of 1.26 million shares, in comparison to 1.44 million shares of average trading volume. So far this year, the stock is down -91.79%.
The company has a total market capitalization of $58.48 million and its total outstanding shares are 37.49 million. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Has AFFY Found The Bottom and Ready To Move Up? Find Out Here
ValueClick Inc(NASDAQ:VCLK) plunged -1.26% and closed at $21.16 on a traded volume of 1.24 million shares, whereas its average trading volume is 1.30 million shares. In the last three months, the stock is down -19.73%. The Intra-day range for the stock is $21.13 and $21.69. ValueClick, Inc., together with its subsidiaries, offers a suite of products and services that enable marketers to advertise and sell their products and services primarily through online and mobile display advertising, affiliate marketing, and comparison shopping channels.
Has VCLK Found The Bottom And Ready To Gain Momentum? Find Out Here
United Online, Inc.(NASDAQ:UNTD) dropped down -3.68% and closed at $7.85. So far in three months, the stock is up +15.27%. The 52-week range for the stock is $4.98 and $8.90 and during the previous trading session the stock touched its highest price at $8.21. Its introductory price for the day was $8.12, with the overall traded volume of 1.24 million shares. United Online, Inc., through its subsidiaries, provides consumer products and services over the Internet primarily in the United States, Canada, and Europe.
Why Should Investors Buy UNTD After the Recent Fall? Just Go Here and Find Out
Keryx Biopharmaceuticals(NASDAQ:KERX), after opening its shares at the price of $8.69, dropped 5.6% to close at $8.53 for the day. The stock moved on a traded volume of 1.24 million shares, in comparison to 1.67 million shares of average trading volume.
The 52-week range for the stock is $2.00 and $9.98 and during the previous trading session the stock touched its highest price at $8.76. Its introductory price for the day was $8.69. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Will KERX Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)